Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Similar articles for PubMed (Select 22997017)

1.

Advances in childhood cancers: whole-genome sequencing has helped identify cancer subtypes and potential targets for therapy.

Printz C.

Cancer. 2012 Oct 1;118(19):4639-40. doi: 10.1002/cncr.27827. No abstract available.

2.

Second cancers after medulloblastoma: population-based results from the United States and Sweden.

Goldstein AM, Yuen J, Tucker MA.

Cancer Causes Control. 1997 Nov;8(6):865-71.

PMID:
9427429
3.

Progress in sequencing human cancer genomes: advancements in childhood medulloblastoma.

Komotar RJ, Starke RM, Connolly ES, Sisti MB.

Neurosurgery. 2011 Oct;69(4):N13-5. doi: 10.1227/01.neu.0000405592.55589.c6. No abstract available.

PMID:
21900800
4.

Curability of cancer in childhood and adolescence: acute lymphoblastic leukemia.

Mann G, Gadner H.

Wien Klin Wochenschr. 2002 Feb 28;114(4):141-2. No abstract available.

PMID:
12060979
5.

Shortage of chemotherapeutic agents in Iraq and outcome of childhood acute lymphocytic leukemia, 1990-2002.

Frangoul H, Al-Jadiry MF, Shyr Y, Ye F, Shakhtour B, Al-Hadad SA.

N Engl J Med. 2008 Jul 24;359(4):435-7. doi: 10.1056/NEJMc0803444. No abstract available.

6.

A strategy for oligonucleotide microarray probe reduction.

Antipova AA, Tamayo P, Golub TR.

Genome Biol. 2002;3(12):RESEARCH0073. Epub 2002 Nov 25.

7.

Risk-adapted chemotherapy in childhood medulloblastoma.

Varan A.

Expert Rev Anticancer Ther. 2011 May;11(5):771-80. doi: 10.1586/era.10.222. Review.

PMID:
21554052
8.

DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials.

Hiddemann W, Harbott J, Ludwig WD, Ritter J, Nehmer A, Reiter A, Kolkmeyer A, Laing T, Riehm H.

Recent Results Cancer Res. 1993;131:113-21. No abstract available.

PMID:
8210632
9.

Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease.

Ellison DW.

Acta Neuropathol. 2010 Sep;120(3):305-16. doi: 10.1007/s00401-010-0726-6. Epub 2010 Jul 23. Review.

PMID:
20652577
10.

Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.

Relling MV, Ramsey LB.

Hematology Am Soc Hematol Educ Program. 2013;2013:126-30. doi: 10.1182/asheducation-2013.1.126. Review.

11.

Medulloblastoma.

Padovani L, André N, Gentet JC, Muracciole X.

Eur J Cancer. 2011 Sep;47 Suppl 3:S338. doi: 10.1016/S0959-8049(11)70194-0. No abstract available.

PMID:
21944006
12.

What's new in neuro-oncology? Recent advances in medulloblastoma.

Ellison DW, Clifford SC, Gajjar A, Gilbertson RJ.

Eur J Paediatr Neurol. 2003;7(2):53-66. Review. No abstract available.

PMID:
12697428
13.

Medulloblastoma as a secondary malignancy after radiotherapy-free treatment for acute lymphoblastic leukemia.

Schiavetti A, Clerico A, De Pasquale MD, Bernardini L, Moleti ML.

J Pediatr Hematol Oncol. 2003 Jul;25(7):562-4.

PMID:
12847325
14.

Biology and treatment of acute lymphoblastic leukemia.

Pieters R, Carroll WL.

Pediatr Clin North Am. 2008 Feb;55(1):1-20, ix. doi: 10.1016/j.pcl.2007.11.002. Review.

PMID:
18242313
15.

Acute lymphoblastic leukemia in adolescents and young adults in Finland.

Usvasalo A, Räty R, Knuutila S, Vettenranta K, Harila-Saari A, Jantunen E, Kauppila M, Koistinen P, Parto K, Riikonen P, Salmi TT, Silvennoinen R, Elonen E, Saarinen-Pihkala UM.

Haematologica. 2008 Aug;93(8):1161-8. doi: 10.3324/haematol.12466. Epub 2008 Jun 12.

16.

Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.

Pulte D, Gondos A, Brenner H.

J Natl Cancer Inst. 2008 Sep 17;100(18):1301-9. doi: 10.1093/jnci/djn276. Epub 2008 Sep 9.

17.

Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials.

Harbott J, Ritterbach J, Ludwig WD, Bartram CR, Reiter A, Lampert F.

Recent Results Cancer Res. 1993;131:123-32. No abstract available.

PMID:
8210633
18.

Genome study suggests new treatments for high-risk form of childhood leukemia.

McBride D.

ONS Connect. 2012 Nov;27(11):21. No abstract available.

PMID:
23316525
19.

Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.

Yamaji K, Okamoto T, Yokota S, Watanabe A, Horikoshi Y, Asami K, Kikuta A, Hyakuna N, Saikawa Y, Ueyama J, Watanabe T, Okada M, Taga T, Kanegane H, Kogawa K, Chin M, Iwai A, Matsushita T, Shimomura Y, Hori T, Tsurusawa M; Japanese Childhood Cancer Leukemia Study Group.

Pediatr Blood Cancer. 2010 Dec 15;55(7):1287-95. doi: 10.1002/pbc.22620.

PMID:
20535816
20.

Reaping the benefits of recent advances for adults with acute lymphoblastic leukemia.

Brown PA, Alvarnas JC.

J Natl Compr Canc Netw. 2012 Jul 1;10(7):800-1. No abstract available.

PMID:
22773795
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk